Avanafil
113 interactions 1 explained in plain English 299 cited referencesAvanafil is used to treat erectile dysfunction (ED: impotence; inability to get or keep an erection in men). Avanafil is in a class of medications called phosphodiesterase (PDE) inhibitors. It works by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Avanafi… Read the full Avanafil drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Moderate
Avanafil Trospium / Xanomeline Cobenfy Explained Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-r... Details Avanafil Alfuzosin UroXatral Increased risk of hypotension Details Avanafil Amprenavir Decreased avanafil clearance and increased avanafil plasma concentrations Details Avanafil Aprepitant Aponvie Increased avanafil exposure Details Avanafil Artemether Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Avanafil Bunazosin Increased risk of hypotension Details Avanafil Ciprofloxacin Increased avanafil exposure Details Avanafil Crizotinib Xalkori Increased avanafil exposure Details Avanafil Cyclosporine Atopica Increased avanafil exposure Details Avanafil Dapiprazole Increased risk of hypotension Details Avanafil Diltiazem Cardizem Decreased avanafil clearance and increased avanafil plasma concentrations Details Avanafil Doxazosin Cardura Increased risk of hypotension Details Avanafil Dronedarone Multaq Increased avanafil exposure Details Avanafil Fluvoxamine Increased avanafil exposure Details Avanafil Fosamprenavir Lexiva Decreased avanafil clearance and increased avanafil plasma concentrations Details Avanafil Fosaprepitant Emend Injection Increased avanafil exposure Details Avanafil Imatinib Gleevec Increased avanafil exposure Details Avanafil Kratom Increased CYP3A substrate exposure Details Avanafil Letermovir Prevymis Increased avanafil exposure Details Avanafil Mavacamten Camzyos Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Avanafil Moxisylyte Increased risk of hypotension Details Avanafil Nilotinib Increased avanafil exposure Details Avanafil Phenoxybenzamine Dibenzyline Increased risk of hypotension Details Avanafil Phentolamine Increased risk of hypotension Details Avanafil Prazosin Minipress Increased risk of hypotension Details Avanafil Rifampin Rifadin Potential for decreased avanafil exposure Details Avanafil Rilzabrutinib Wayrilz Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related adverse reactions Details Avanafil Silodosin Rapaflo Increased risk of hypotension Details Avanafil Tamsulosin Flomax Increased risk of hypotension Details Avanafil Trimazosin Increased risk of hypotension Details Avanafil Urapidil Increased risk of hypotension Details Avanafil Verapamil Calan Decreased avanafil clearance and increased avanafil plasma concentrations Details Avanafil Xanomeline Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-r... Details Avanafil Cyclosporine Injection Atopica Increased avanafil exposure Details Avanafil Cyclosporine Ophthalmic Cequa Increased avanafil exposure Details Avanafil Letermovir Injection Prevymis Increased avanafil exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist